- Home
- ZCMD vs OCX Comparison
ZCMD vs OCX Comparison
Compare ZCMD & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- OCX
- Stock Information
- Founded
- ZCMD 2012
- OCX 2009
- Country
- ZCMD China
- OCX United States
- Employees
- ZCMD N/A
- OCX N/A
- Industry
- ZCMD Other Consumer Services
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ZCMD Real Estate
- OCX Health Care
- Exchange
- ZCMD Nasdaq
- OCX Nasdaq
- Market Cap
- ZCMD 35.3M
- OCX 80.1M
- IPO Year
- ZCMD 2020
- OCX N/A
- Fundamental
- Price
- ZCMD $1.20
- OCX $3.87
- Analyst Decision
- ZCMD
- OCX Buy
- Analyst Count
- ZCMD 0
- OCX 3
- Target Price
- ZCMD N/A
- OCX $4.42
- AVG Volume (30 Days)
- ZCMD 4.4K
- OCX 120.1K
- Earning Date
- ZCMD 01-01-0001
- OCX 04-11-2025
- Dividend Yield
- ZCMD N/A
- OCX N/A
- EPS Growth
- ZCMD N/A
- OCX N/A
- EPS
- ZCMD N/A
- OCX N/A
- Revenue
- ZCMD $17,406,104.00
- OCX $709,000.00
- Revenue This Year
- ZCMD N/A
- OCX N/A
- Revenue Next Year
- ZCMD N/A
- OCX $106.34
- P/E Ratio
- ZCMD N/A
- OCX N/A
- Revenue Growth
- ZCMD 1.01
- OCX N/A
- 52 Week Low
- ZCMD $1.00
- OCX $1.92
- 52 Week High
- ZCMD $2.97
- OCX $4.75
- Technical
- Relative Strength Index (RSI)
- ZCMD 39.15
- OCX 71.87
- Support Level
- ZCMD $1.21
- OCX $3.60
- Resistance Level
- ZCMD $1.53
- OCX $4.75
- Average True Range (ATR)
- ZCMD 0.10
- OCX 0.47
- MACD
- ZCMD 0.00
- OCX 0.10
- Stochastic Oscillator
- ZCMD 0.00
- OCX 63.77
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.